Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
Theraheart has raised $20.6M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Theraheart's investors include Qiming Venture Partners.
Theraheart is headquartered in Irvine, United States.
Theraheart is a medical device company that offers innovative, minimally invasive solutions for heart failure.
Theraheart is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Theraheart — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/theraheart. Accessed July 19, 2026.
VCBacked. (2025). Theraheart — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/theraheart
{{cite web |title=Theraheart — Funding & Investors |url=https://www.vcbacked.co/company/theraheart |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated